Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. - Wikidata - wikimedia - TriplyDB

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

http://www.wikidata.org/entity/Q41516719

about

Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?Triazole Resistance in Aspergillus Species: An Emerging Problem.Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.Current State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States.A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence.Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia Environmental isolates of azole-resistant Aspergillus fumigatus in Germany In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins.Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.Immunotherapy for opportunistic infections: Current status and future perspectives.Updated guidelines for the diagnosis and management of aspergillosis.Global Population Genetic Analysis of Aspergillus fumigatus.Our 2015 approach to invasive pulmonary aspergillosis.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Diagnostics and susceptibility testing in Aspergillus.Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis.Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment.Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease.Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital.Azole-resistant Aspergillus fumigatus in sawmills of Eastern France.FunResDB-A web resource for genotypic susceptibility testing of Aspergillus fumigatus.High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.[Resistant fungi].First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.Multi-triazole-resistant Aspergillus fumigatus infections in Australia.Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis.Emergence of TR46/Y121F/T289A in an Aspergillus fumigatus isolate from a Chinese patient.Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?

P2860

Q28081259-0F68AA64-F282-4D1F-BCAF-DDBF7097A4DB Q28082352-55F9EF27-FB72-4D10-833E-CECAC0CA6744 Q29994504-5B92238B-8D44-4630-8D1C-686895FC13C3 Q30235566-93D10D87-D560-48DB-9C74-DCD0F32D1B2C Q30239051-DDCAC1C2-D1E8-4321-9929-E5BBC6838876 Q33782852-50B620D1-80A9-4855-A300-5744251FA50E Q33843857-0A9B07F5-5B2A-4C05-AC8D-DE96D89F23EF Q35585364-4E758E47-7FF8-4D38-91B3-135928AA9DDE Q35746075-8CEFEB69-74CF-4DCF-A5CE-5234548C35AC Q36439109-3D33C3C5-60AC-4597-A559-195B7D325C5E Q36562397-70A0C603-0C78-4CA9-AA6C-265499C14CDC Q37287782-7D3C8E5F-C1ED-4F79-B104-74652C7BA14E Q37509216-3A20D6B2-8546-45A9-B93A-75EC91723B36 Q37581266-6749EFBE-7366-4D2E-AFD3-E6BB3797EEB8 Q37620315-5DBDC71E-9814-40FA-8B88-E0DB6A2E22DA Q38391049-799CABE3-9C24-4944-8292-E551E2A292EF Q38711698-ADD3282D-653A-4480-8642-E70FDFF4D9FF Q38723910-7772021D-E032-4F77-BBEC-A4F919B80CF5 Q38786258-045E4233-56EB-4EAD-AA22-28CA0EBAE922 Q39023027-396D5B81-C117-451D-8D14-8E601F10E1A0 Q39196802-81E168FA-D4EC-402F-96DF-DB757B0E7F10 Q39473672-D8CB32E6-13D9-47AF-92FD-1A68C9BEA01E Q39520292-C97640D8-BEDB-4D91-9519-D80A1D2EDFA9 Q40035285-7EEE1014-F52D-4037-9818-114D03483AFF Q40040786-50A56BA6-B42C-4E1C-B79C-7EF48694E053 Q40045642-BBA2F659-9B58-4252-98F1-EA6BD329E5E4 Q40083822-24836453-E713-47ED-8778-FB3AF1C2D240 Q40119990-7F107ADB-1768-48FD-9F16-15492A4E7017 Q40197804-47D17474-47F5-4940-83B5-3BF611CBB0F7 Q40215709-465D74F1-5152-4D78-81B9-A072319E16D1 Q40279608-AF19F225-592A-497A-AD87-3F4C4EC362D4 Q40749403-AA2F4445-A73F-4740-947C-A7DDF5E803FB Q40968242-642A11EB-FF35-4E18-9DEA-C93816D36DE0 Q41280441-2C9F030C-77F2-4B71-8EEF-949B72D1A4C0 Q41321727-5A9C67FF-25D9-4241-9692-9AF99B890E63 Q42103290-EFDCC226-5C89-4356-9E3B-7E5E20C68C60 Q43223520-6D0DE29E-35B8-46BB-BFD7-E87B4F86B303 Q46247336-9BF3C14F-083D-424A-85F2-7158C5A9F582 Q46307503-88279976-67AF-4182-96DF-5D1B5A5DD9D7 Q47850725-5FFA5D9F-67C1-4483-91B7-8506ED14927C

P2860

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

http://www.wikidata.org/entity/Q41516719

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

@en

type

label

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

@en

prefLabel

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

@en

P1433

Q41516719-A3AEB786-DD8A-424C-A79B-85EA4B063438

P1476

Q41516719-A569B876-85C3-4845-A8FC-D6741A847220

P2093

Q41516719-103999AC-D64A-4E1F-A77F-66B177C96134

Q41516719-202CA740-C941-4E60-9E13-D0E06EE12419

Q41516719-73389B4F-6002-4170-8DFC-E25605B08665

Q41516719-9AABE58F-7459-4E2B-8102-D443594AAD09

Q41516719-C50E74BC-613C-431D-863C-317A257C18EF

Q41516719-DE0B5830-9BA2-484D-BDB2-A7E263D43334

P2860

Q41516719-02E342D9-090B-4D48-BFCC-261D3A7FA76D

Q41516719-141DFB8E-C363-4BFE-949F-281E784EB09B

Q41516719-223FBD7A-6181-47F2-8AF7-6C00FE0C92B2

Q41516719-2AC87269-905D-41AA-B0F4-DAC44187853F

Q41516719-2D129E8F-AC07-4D55-9EFA-AAB1DE08F337

Q41516719-463EB701-6231-4FEC-AF2C-612068118C6F

Q41516719-4C4112DA-5F1B-47C5-BEDE-CBA780FBDFE3

Q41516719-67634BBF-8ADC-4FB1-9C8A-D10790CB1E5D

Q41516719-726026CD-10BB-4942-9DA5-CECFDE658E0B

Q41516719-78C10B39-483C-4081-BB77-A095F2523B92

P304

Q41516719-22233727-555A-4275-B1C2-4DFF5D755CAB

P31

Q41516719-EBA0F3D6-5A65-4904-AFE9-76D75BAC7448

P356

Q41516719-A80C5379-538A-4A41-9E4B-67E9481BB0E5

P407

Q41516719-D2812A1E-4BE2-4303-A1F7-E0C85E7C3F71

P433

Q41516719-5795FA4C-5F26-4DE5-8BF4-DC8B713A018A

P478

Q41516719-05C615B7-3DC0-45BA-B6DD-A2F8A56F8A0A

P50

Q41516719-25323FC3-FC48-4218-9802-3BFEC318682D

Q41516719-37999029-286D-4EB7-A3B7-1FFCE2808A67

Q41516719-3D6A6CF5-9924-44EB-89B0-4ED497003298

Q41516719-629BA0CB-DEA7-44F5-8505-6F96CD04200D

P577

Q41516719-4916C57E-8DE8-4384-BA5C-F3F6BA6DE8CE

P5875

Q41516719-6ADA48F1-8469-453D-8138-6333E95B13AA

P698

Q41516719-9D1029C0-1CFC-44FD-87AC-556C1BB6D9E3

P921

Q41516719-57CC02BB-8BB5-49D1-B705-E62664CF211C

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

@en

P2093

B Spiess

http://www.w3.org/2001/XMLSchema#string

J Buer

http://www.w3.org/2001/XMLSchema#string

J Steinmann

http://www.w3.org/2001/XMLSchema#string

M J G T Vehreschild

http://www.w3.org/2001/XMLSchema#string

M Koldehoff

http://www.w3.org/2001/XMLSchema#string

P-M Rath

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.

Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.

Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009.

Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism.

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

P304

1522-1526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKU566

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Dieter Buchheidt

Jacques F. Meis

Oliver A Cornely

P577

2015-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271597383

http://www.w3.org/2001/XMLSchema#string

P698

25630644

http://www.w3.org/2001/XMLSchema#string

P921